A study conducted in China found that nearly 70% of Chinese T2D patients received insulin therapy, but less than 20% of them reached the glycated hemoglobin A1c (HbA1c) target (HbA1c<7.0) (9). The gene discussed is INS; the disease is type 2 diabetes mellitus.